bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF )
1.723
-0.017
(-0.98%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about bioAffinity Technologies, Inc. - Common Stock
![](https://mms.businesswire.com/media/20230907441683/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230814966396/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230712526323/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230615885384/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230522005222/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230515005205/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230501005136/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230425005119/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230405005222/en/797416/22/bioAfinity_logo.jpg)
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
April 05, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230331005441/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230328005298/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230324005073/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230213005204/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230124005372/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230104005332/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221215005348/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221201005338/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221114005386/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221110005448/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221108005478/en/797416/5/bioAfinity_logo.jpg)
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
November 08, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221025005345/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20221012005471/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20220928005404/en/797416/5/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20220914005215/en/797416/5/bioAfinity_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.